Lakshminarayanan Ragupathy, of HLL Lifecare Limited, has won the grant for the project, among 50 ideas selected as a part of the Grand Challenges Explorations (GCE) Round-12 funded by the Foundation, company's Chairman and Managing Director M Ayyappan said in a statement today.
Commenting on the award, Ragupathy, who works at HLL's state-of-the-art Corporate R&D Centre, said it would be his endeavour to develop extremely thin and bio-degradable condoms, which will ensure increased use in the days to come.
The GCE funds individuals worldwide to explore game-changing ideas that can break the mould in resolving persistent global health and development challenges.
A polymer scientist, Ragupathy joined HLL in 2012.
Earlier, he had worked as a post-doctoral fellow at University of Ulm, Max Planck Institute for Polymer Research, Germany; and University of Manchester, UK. He obtained his PhD from Heriot-Watt University, UK in 2006.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
